Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-14

Clinical Trial Update: Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the efficacy and safety of A-prexa compared with Zyprexa (olanzapine) in patients with schizophrenia-spectrum disorders and has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • A-prexa
  • Zyprexa (olanzapine)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Schizophrenia, Schizophreniform Disorder | Phase 4 | Status: COMPLETED